DIALECTIC CAPITAL MANAGEMENT LP 13D and 13G filings for Achieve Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-04-18 5:18 pm Purchase | 2023-04-18 | 13G | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,593,093 19.990% | 44,093 (+1.24%) | Filing |
| 2023-03-23 4:45 pm Unchanged | 2023-03-21 | 13D | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 0 (Unchanged) | Filing |
| 2023-03-06 10:43 am Unchanged | 2023-03-01 | 13D | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 0 (Unchanged) | Filing |
| 2023-01-20 3:02 pm Unchanged | 2023-01-19 | 13D | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 0 (Unchanged) | Filing |
| 2022-11-21 4:41 pm Purchase | 2022-11-18 | 13G | Achieve Life Sciences, Inc. ACHV | DIALECTIC CAPITAL MANAGEMENT LP | 3,549,000 19.800% | 3,549,000 (New Position) | Filing |